Clean Science and Technology (CLEAN) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
9 Jul, 2026Executive summary
Standalone revenue declined 5% sequentially to INR 206 crore and 8% year-over-year, mainly due to lower sales in established products.
EBITDA margin remained strong at 44% for the quarter, with a 2% year-over-year improvement due to favorable product mix.
Consolidated revenue was steady at INR 240 crore, with consolidated EBITDA and PAT at INR 87 crore and INR 55 crore, respectively.
Achieved resilient EBITDA margins in Q2 FY2026 due to a favorable product mix and ongoing benefits from new product launches.
Export revenues comprised 63% of consolidated revenues, reflecting a strong global presence.
Approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.
Financial highlights
Standalone EBITDA for the quarter was INR 90 crore, down 10% sequentially and 5% year-over-year.
Q2 FY2026 consolidated revenue was ₹245 crore, up 3% year-over-year; EBITDA margin at 41.7%.
H1 FY2026 consolidated revenue grew 6% year-over-year to ₹488 crore; EBITDA margin at 38.9%.
Standalone revenue from operations for H1 FY26 was ₹4,312.20 million, down from ₹4,453.74 million year-over-year.
Standalone net profit for H1 FY26 was ₹1,412.09 million, compared to ₹1,395.93 million in H1 FY25.
Outlook and guidance
Management expects Q3 to be flat, with growth anticipated in Q4 as new products contribute.
Benefits of operating leverage expected as newly launched products scale in revenue.
Board and management continue to focus on sustainability and innovation, with ongoing director appointments to strengthen governance.
Latest events from Clean Science and Technology
- Record FY22 growth, margin pressure and capacity-led expansion plans.CLEAN
Q4 21/22 - FY21 revenue and profit rose despite COVID disruptions; IPO planned as an offer for sale.CLEAN
Q4 20/21 - Destocking reduced FY24 earnings, while HALS capacity and product diversification advanced growth plans.CLEAN
Q4 23/24 - Record FY23 growth, HALS expansion and disciplined funding underpin the outlook.CLEAN
Q4 22/23 - Q1 FY27 revenue hit ₹2,684.32 million, led by HALS growth and global expansion initiatives.CLEAN
Q1 26/27 - Record HALS sales and margin gains drive Q4 growth; ₹4/share dividend declared.CLEAN
Q4 25/26 - Revenue and profit declined YoY, but margins held and ₹2 interim dividend was declared.CLEAN
Q3 25/26 - Strong revenue and profit growth in Q2 FY25, led by performance chemicals and export demand.CLEAN
Q2 24/25 - Record sales, 22% revenue growth, strong margins, and a ₹4 dividend support future growth.CLEAN
Q4 24/25